Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:18 PM
Ignite Modification Date:
2025-12-24 @ 12:18 PM
NCT ID:
NCT00822861
Eligibility Criteria:
Inclusion Criteria:
* Men and women 18 to 65 years of age
* Generally good health; steroid naïve (or who have not taken inhaled/oral corticosteroid within last month) mild to moderate, stable, allergic asthma as defined by ATS criteria
* History of episodic wheeze and shortness of breath
* Forced expiratory volume in one second (FEV1) at baseline ≥ 70% of the predicted value
* Able to comprehend and follow all required study procedures; willing and able to sign an informed consent form.
Exclusion Criteria:
* Significant acute or chronic medical or psychiatric illness
* Known coagulopathy, worsening of asthma or respiratory infection in the preceding 6 weeks
* Use of inhaled or oral corticosteroids within the last 30 days, or need for antihistamines within 72 hours of each allergen or methacholine challenge, immunosuppressives, nonsteroidal anti-inflammatory drugs, or anticoagulants (intermittent doses of short-acting β2-agonist are allowed).
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00822861
Study Brief:
Protocol Section:
NCT00822861